See also this year's filing and all EDGAR filings for this company.
PDF Report 0001505512_2023_Regulus_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001505512, Regulus Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 44,079,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 62,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 2,575,000 |
| 4 | LiabilitiesCurrent | 11,657,000 |
| 5 | LiabilitiesNoncurrent | 1,768,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,668,748 |
| 9 | ResearchAndDevelopmentExpense | 19,169,373 |
| 10 | remainder_Expenses | 560,509 |
| 11 | remainder_Revenues | 676,590 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -6,929 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 46,716,000 |
| 1 | Liabilities | 13,425,000 |
| 2 | Expenses | 29,398,630 |
| 3 | Revenues | 676,590 |
| 4 | StockholdersEquity | 33,291,000 |
| 5 | NetIncome | -28,722,040 |
| 6 | ComprehensiveNetIncome | -28,725,504 |
| 7 | BaseVar | 45,111,574 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.46 |
| 9 | EconomicCapitalRatio | 2.65 |
Edgar->Model Mapping
Feature Distribution
Change over Time
